Cargando…

Artificial sweeteners and risk of cardiovascular diseases in the prospective NutriNet-Santé cohort

BACKGROUND: Artificial sweeteners are widely used today by the food industry as sugar alternatives. Potential adverse effects of these food additives on cardiovascular disease (CVD) have been suggested in experimental studies, but data from studies involving humans remain very limited. Previous coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Debras, C, Chazelas, E, Sellem, L, Julia, C, Kesse-Guyot, E, Allès, B, Deschasaux-Tanguy, M, Huybrechts, I, Srour, B, Touvier, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593923/
http://dx.doi.org/10.1093/eurpub/ckac129.013
_version_ 1784815283718848512
author Debras, C
Chazelas, E
Sellem, L
Julia, C
Kesse-Guyot, E
Allès, B
Deschasaux-Tanguy, M
Huybrechts, I
Srour, B
Touvier, M
author_facet Debras, C
Chazelas, E
Sellem, L
Julia, C
Kesse-Guyot, E
Allès, B
Deschasaux-Tanguy, M
Huybrechts, I
Srour, B
Touvier, M
author_sort Debras, C
collection PubMed
description BACKGROUND: Artificial sweeteners are widely used today by the food industry as sugar alternatives. Potential adverse effects of these food additives on cardiovascular disease (CVD) have been suggested in experimental studies, but data from studies involving humans remain very limited. Previous cohorts have focused on artificially sweetened beverages. Our objective was to study the associations between artificial sweeteners from all dietary sources, overall and by molecule (aspartame, acesulfame-potassium and sucralose), and risk of CVDs (overall, coronary heart and cerebrovascular). METHODS: The study included 103,388 participants of the web-based NutriNet-Santé cohort (2009-2021). Artificial sweetener intakes were assessed using repeated 24h dietary records including names and brands of industrial products consumed. Multi-adjusted Cox proportional hazard models were performed. Exposure to artificial sweeteners were coded as 3-category variables: non-consumers, lower consumers (artificial sweetener intake below the sex-specific median) and higher consumers (above the sex-specific median). RESULTS: Compared to non-consumers, higher consumers of total artificial sweeteners had increased risk for CVD (n = 1502 incident cases, HR = 1.17 [1.01-1.35], P-trend=0.04) and more specifically cerebrovascular diseases (n = 777, HR = 1.34 [1.10-1.62], P = 0.004). Higher consumption of aspartame was associated with increased cerebrovascular diseases (HR = 1.29 [1.03-1.60], P = 0.01). Higher consumption of acesulfame-K was associated with a higher risk of CVD (HR = 1.24 [1.04-1.47], P = 0.02) and cerebrovascular diseases (HR = 1.29 [1.02-1.64], P = 0.1). No association was detected for coronary heart diseases (n = 730 incident cases). CONCLUSIONS: These findings suggest a direct association between higher artificial sweetener consumption and increased CVD risk, in particular cerebrovascular. These results provide key novel information for the ongoing re-evaluation of sweeteners by the European Food Safety Authority. KEY MESSAGES: • In this large-scale prospective cohort (n = 103,388), artificial sweeteners (especially aspartame and acesulfame-K) were associated with increased risks of cardiovascular and cerebrovascular diseases. • These results provide key insights to feed EFSA’s expertise for the ongoing risk assessment of artificial sweeteners.
format Online
Article
Text
id pubmed-9593923
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95939232022-11-22 Artificial sweeteners and risk of cardiovascular diseases in the prospective NutriNet-Santé cohort Debras, C Chazelas, E Sellem, L Julia, C Kesse-Guyot, E Allès, B Deschasaux-Tanguy, M Huybrechts, I Srour, B Touvier, M Eur J Public Health Parallel Programme BACKGROUND: Artificial sweeteners are widely used today by the food industry as sugar alternatives. Potential adverse effects of these food additives on cardiovascular disease (CVD) have been suggested in experimental studies, but data from studies involving humans remain very limited. Previous cohorts have focused on artificially sweetened beverages. Our objective was to study the associations between artificial sweeteners from all dietary sources, overall and by molecule (aspartame, acesulfame-potassium and sucralose), and risk of CVDs (overall, coronary heart and cerebrovascular). METHODS: The study included 103,388 participants of the web-based NutriNet-Santé cohort (2009-2021). Artificial sweetener intakes were assessed using repeated 24h dietary records including names and brands of industrial products consumed. Multi-adjusted Cox proportional hazard models were performed. Exposure to artificial sweeteners were coded as 3-category variables: non-consumers, lower consumers (artificial sweetener intake below the sex-specific median) and higher consumers (above the sex-specific median). RESULTS: Compared to non-consumers, higher consumers of total artificial sweeteners had increased risk for CVD (n = 1502 incident cases, HR = 1.17 [1.01-1.35], P-trend=0.04) and more specifically cerebrovascular diseases (n = 777, HR = 1.34 [1.10-1.62], P = 0.004). Higher consumption of aspartame was associated with increased cerebrovascular diseases (HR = 1.29 [1.03-1.60], P = 0.01). Higher consumption of acesulfame-K was associated with a higher risk of CVD (HR = 1.24 [1.04-1.47], P = 0.02) and cerebrovascular diseases (HR = 1.29 [1.02-1.64], P = 0.1). No association was detected for coronary heart diseases (n = 730 incident cases). CONCLUSIONS: These findings suggest a direct association between higher artificial sweetener consumption and increased CVD risk, in particular cerebrovascular. These results provide key novel information for the ongoing re-evaluation of sweeteners by the European Food Safety Authority. KEY MESSAGES: • In this large-scale prospective cohort (n = 103,388), artificial sweeteners (especially aspartame and acesulfame-K) were associated with increased risks of cardiovascular and cerebrovascular diseases. • These results provide key insights to feed EFSA’s expertise for the ongoing risk assessment of artificial sweeteners. Oxford University Press 2022-10-25 /pmc/articles/PMC9593923/ http://dx.doi.org/10.1093/eurpub/ckac129.013 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Parallel Programme
Debras, C
Chazelas, E
Sellem, L
Julia, C
Kesse-Guyot, E
Allès, B
Deschasaux-Tanguy, M
Huybrechts, I
Srour, B
Touvier, M
Artificial sweeteners and risk of cardiovascular diseases in the prospective NutriNet-Santé cohort
title Artificial sweeteners and risk of cardiovascular diseases in the prospective NutriNet-Santé cohort
title_full Artificial sweeteners and risk of cardiovascular diseases in the prospective NutriNet-Santé cohort
title_fullStr Artificial sweeteners and risk of cardiovascular diseases in the prospective NutriNet-Santé cohort
title_full_unstemmed Artificial sweeteners and risk of cardiovascular diseases in the prospective NutriNet-Santé cohort
title_short Artificial sweeteners and risk of cardiovascular diseases in the prospective NutriNet-Santé cohort
title_sort artificial sweeteners and risk of cardiovascular diseases in the prospective nutrinet-santé cohort
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593923/
http://dx.doi.org/10.1093/eurpub/ckac129.013
work_keys_str_mv AT debrasc artificialsweetenersandriskofcardiovasculardiseasesintheprospectivenutrinetsantecohort
AT chazelase artificialsweetenersandriskofcardiovasculardiseasesintheprospectivenutrinetsantecohort
AT selleml artificialsweetenersandriskofcardiovasculardiseasesintheprospectivenutrinetsantecohort
AT juliac artificialsweetenersandriskofcardiovasculardiseasesintheprospectivenutrinetsantecohort
AT kesseguyote artificialsweetenersandriskofcardiovasculardiseasesintheprospectivenutrinetsantecohort
AT allesb artificialsweetenersandriskofcardiovasculardiseasesintheprospectivenutrinetsantecohort
AT deschasauxtanguym artificialsweetenersandriskofcardiovasculardiseasesintheprospectivenutrinetsantecohort
AT huybrechtsi artificialsweetenersandriskofcardiovasculardiseasesintheprospectivenutrinetsantecohort
AT srourb artificialsweetenersandriskofcardiovasculardiseasesintheprospectivenutrinetsantecohort
AT touvierm artificialsweetenersandriskofcardiovasculardiseasesintheprospectivenutrinetsantecohort